![Alex Gregory Sturmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Gregory Sturmer is the founder and currently serves as the Chief Executive Officer of Elysium Therapeutics, Inc., a company founded in 2013.
Mr. Sturmer has also held the position of Chief Financial Officer & Vice President at Signature Therapeutics, Inc. and Vice President-Finance at Innoviva, Inc. In terms of education, Mr. Sturmer has an undergraduate degree from The California State University and an MBA from Pepperdine University.
| Unternehmen | Position | Beginn |
|---|---|---|
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Vorstandsvorsitzender | 01.01.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Finanzdirektor/CFO | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
